Masimo (MASI) Fights Politan in a Bid to Retain CEO on Board
Masimo's (MASI) WI Sport Wearable Gets a New Powerful Feature
Masimo Shares Are Trading Lower After COO Bilal Muhsin Threatened to Resign If CEO Joe Kiani Is Removed.
Masimo Shares Are Trading Lower After COO Bilal Muhsin Threatened to Resign If CEO Joe Kiani Is Removed.
Express News | Shares of Masimo Corp Down 6.5% After COO Muhsin Says He Will Resign IF Activist Investor Politan Takes Control
Masimo Announces Sleep Halo, Advanced Sleep Analysis For The Masimo W1
Sleep Halo Sleep Metrics Are Based on Masimo W1's Continuous Pulse Oximetry Measurements and Advanced Halo AI TechnologyMasimo (NASDAQ:MASI), today announced that the Masimo W1 Sport advanced health t
Masimo COO Threatens Resignation Amidst Investment Talks
Express News | Masimo Corp -Bilal's Conditional Resignation Letter in Event That Joe Kiani Is Removed as Co’s Chairman of Board and Chief Executive Officer
Masimo COO Bilal Muhsin Threatens Resignation If CEO Joe Kiani Is Removed
On June 26, 2024, Bilal Muhsin, the Chief Operating Officer of Masimo Corporation (the "Company") sent a letter (the "Muhsin Conditional Resignation Letter") to Craig Reynolds, the Lead Independent Di
Express News | Masimo Corp -on June 26, Bilal Muhsin Sent Letter to Craig Reynolds, Notifying of Mushin’s Intent to Resign as Co’s Chief Operating Officer
Cleveland Clinic and Masimo Partner to Improve Remote Patient Monitoring
Express News | Masimo Corp - Collaboration Includes Joint Development Initiatives on Predictive Analytics
Express News | Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care
Heart Just Skip a Beat? Your Watch Already Knows.
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn't worry.
Piper Sandler Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $160
Piper Sandler analyst Jason Bednar maintains $Masimo(MASI.US)$ with a buy rating, and maintains the target price at $160.According to TipRanks data, the analyst has a success rate of 37.7% and a total
Masimo Files Investor Presentation Highlighting Strategic Initiatives To Deliver Robust Growth And Margin Expansion; Politan Is Making A Bid For Control Without Paying A Premium Or Articulating A Clear Plan Seeking To Replace Masimo Founder, Chairman...
Masimo Files Investor Presentation Highlighting Strategic Initiatives To Deliver Robust Growth And Margin Expansion; Politan Is Making A Bid For Control Without Paying A Premium Or Articulating A Clea
U.S. Home Durable Medical Equipment Market Analysis Report 2024-2030 Featuring Compass Health Brands, Invacare, Rotech Healthcare, Medline Industries, Masimo, and ResMed
Masimo Shareholder Politan Capital Campaigns for 2 More Board Seats
Masimo (MASI) investor Politan Capital Management urged other shareholders Wednesday to vote for two Politan nominees to the board, saying the company needs a majority of "truly independent" directors
Express News | Politan: Urges Masimo Shareholders Vote for Both of Politan's Independent Nominees Darlene Solomon and William Jellison
Express News | Politan: "Truly Independent Board Is Urgently Needed at Masimo"
Masimo Activist Politan Presents 'Last Chance' for Shareholders to Force Change at Med-tech Company
Masimo activist Politan laid out its renewed case for change in a push to win two more board seats at the medical device company. Politan seeks to oust CEO Joe Kiani from the board and says the company can deliver $10 billion in shareholder value with the right governance and oversight. Masimo shares have slumped 18% since last year's meeting despite Politan winning two board seats.